tailieunhanh - Clinical and economic impact of current ALK rearrangement testing in Spain compared with a hypothetical no-testing scenario

Currently biomarkers play an essential role in diagnosis, treatment, and management of cancer. In non-small cell lung cancer (NSCLC) determination of biomarkers such as ALK, EGFR, ROS1 or PD-L1 is mandatory for an adequate treatment decision. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN